Comparison of Molecular Cytokeratin 19 Reverse Transcriptase Polymerase Chain Reaction (CK19 RT-PCR) and Immunocytochemical Detection of Micrometastatic Breast Cancer Cells in Hematopoietic Harvests
- 1 December 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 6 (6), 551-561
- https://doi.org/10.1089/scd.1.1997.6.551
Abstract
Detection of small numbers of breast cancer cells in patient blood, aphereses, and bone marrow has become increasingly important as data have accumulated showing immunocytochemically (ICC) positive tumor cells in up to 50% of women with stage I and II breast cancer, who were initially thought to be cured of their disease but later relapsed. The ability to rule out the presence of micrometastatic disease at any stage of the clinical management protocol, whether before, during, or after therapy, would provide a useful monitoring and diagnostic tool for both the clinician and the scientist. Monitoring for the presence of minimal residual disease (MRD) is traditionally performed using ICC. A more recently established RT-PCR technique uses a molecular marker (the presence of the cytokeratin 19, CK19, transcript) to identify MRD in patient samples, with a level of sensitivity reported to be one tumor cell in 106 nucleated cells. This level of sensitivity is generally higher than that claimed for ICC. Based on the discriminating results of this first study, a number of laboratories have evaluated this technique for its diagnostic potential. Results from several laboratories showed a higher than expected false positive rate due to a variety of identified and unidentified sources. Therefore, the current study was designed to achieve two aims: to establish the level of sensitivity and specificity of the RT-PCR technique and to dissect out the possible variables that may contribute to a false positive result using this molecular approach. To accomplish the first goal, two simulation strategies were used, limited dilution of tumor cells into apheresis harvests and semiquantitative PCR using stepwise dilutions of extracted RNA from tumor cells in apheresis harvests. The second goal was accomplished by performing sequential blood drawings with variably timed sample processing to identify some of the more common variables (time, anticoagulant, sample sequence) that may contribute to false positive results. Of three variables investigated, including type of blood preservative, sequence of blood tube collection, and time point of sample processing, each may contribute to a false positive result. In addition to these problems, known events involving illegitimate transcription of specific genes nonspecifically in tissue is also a potential source of false positive results. These issues may be further compounded by lack of attention to the more common methodologic problems encountered in any laboratory using the PCR technique. However, recommendations can be developed for the effective application of this technique, whose greatest strength is the demonstration of tumor negativity of the sample.Keywords
This publication has 16 references indexed in Scilit:
- Reversal of RT-PCR Inhibition Observed in Heparinized Clinical SpecimensBioTechniques, 1997
- Immunocytochemical Detection of Breast Cancer Cells: A Comparison of Three Attachment FactorsJournal of Hematotherapy, 1997
- Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Micrometastases and TransplantationJournal of Hematotherapy, 1996
- A Comparison of Immunohistochemistry, Two-Color Immunofluorescence, and Flow Cytometry with Cell Sorting for the Detection of Micrometastatic Breast Cancer in the Bone MarrowJournal of Hematotherapy, 1996
- High Dose versus Standard Dose Chemotherapy for the Treatment of Breast CancerAnnals of the New York Academy of Sciences, 1995
- Access to a Messenger RNA Sequence or Its Protein Product Is Not Limited by Tissue or Species SpecificityScience, 1989
- Illegitimate transcription: transcription of any gene in any cell type.Proceedings of the National Academy of Sciences, 1989
- Transcription of the dystrophin gene in human muscle and non-muscle tissuesNature, 1988
- Patterns of Expression and Organization of Cytokeratin Intermediate FilamentsAnnals of the New York Academy of Sciences, 1985